Another consideration is the accumulation of IgM and IgA among chronic kidney disease patients; due to their high molecular weights, IgM and IgA are not removed by conventional renal replacement treatments such as continuous veno-venous hemodialysis and diafiltration (CVVH and CVVHD, respectively). This evidence concerns the gene CD40LG and chronic kidney disease.